Adipose-Derived Stromal Cells for Treatment of Patients with Chronic Ischemic Heart Disease (MyStromalCell Trial): A Randomized Placebo-Controlled Study

Figure 3

Bicycle exercise test. Primary endpoint (a) time duration, (b) watt, and (c) metabolic equivalents (METs) at baseline, 3, and 6 months follow-up for placebo group and patients treated with adipose-derived stromal cells (ASCs) (values are mean ± 95% confidence interval).

(a)

(b)

(c)